Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma

Detalles Bibliográficos
Autores principales: Lin, Richard J., Lobaugh, Stephanie M., Pennisi, Martina, Chan, Hei Ton, Batlevi, Yakup, Ruiz, Josel D., Elko, Theresa A., Maloy, Molly A., Batlevi, Connie L., Dahi, Parastoo B., Giralt, Sergio A., Hamlin, Paul A., Mead, Elena, Noy, Ariela, Lia Palomba, M., Santomasso, Bianca D., Sauter, Craig S., Scordo, Michael, Shah, Gunjan L., Korc-Grodzicki, Beatriz, Kim, Soo Jung, Silverberg, Mari Lynne, Brooklyn, Chelsea A., Devlin, Sean M., Perales, Miguel-Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776258/
https://www.ncbi.nlm.nih.gov/pubmed/32079691
http://dx.doi.org/10.3324/haematol.2019.243246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776258/
https://www.ncbi.nlm.nih.gov/pubmed/32079691
http://dx.doi.org/10.3324/haematol.2019.243246

Ejemplares similares